Company
Overview
Leadership
Social Accountability
Technology
RJX Technology
Therapeutic Areas
Pipeline
Clinical Trials
Contact
Contact Us
Join Reven
News
Latest News
Research
Investor Portal
2017/09/08 Reven News Press
September 8, 2017
| Featured
Reven received approval for our Family Two 1st Divisional Patent.
More Reven News Releases
|
More Research & Development